Steven Cohen started to build up the position in POINT Biopharma Global in Q1 2022 and continued to invest until Q3 2022. Since then they sold 3.69 Million shares. The investor completely sold their stake between Q4 2022 and Q4 2023.
Avg closing price
Price range
Sold -789 Thousand shares
Q4 2023
Avg closing price
$12.62
Price range
$6.68
-
$13.68
Sold 59.1% shares (-1.14 Million shares)
Q3 2023
Avg closing price
$8.31
Price range
$6.67
-
$9.71
Sold 38.1% shares (-1.19 Million shares)
Q2 2023
Avg closing price
$8.82
Price range
$6.86
-
$10.86
Sold 2.6% shares (-83.2 Thousand shares)
Q1 2023
Avg closing price
$7.42
Price range
$6.78
-
$8.10
Sold 13.4% shares (-495 Thousand shares)
Q4 2022
Avg closing price
$7.42
Price range
$5.72
-
$9.78
Increased shares by 89.0% (+1.74 Million shares)
Q3 2022
Avg closing price
$8.49
Price range
$7.24
-
$10.31
Increased shares by 4523.4% (+1.91 Million shares)
Q2 2022